Retrieve available abstracts of 14 articles: HTML format
Single Articles
April 2025
GAO M, Ma X Accurately Predicting Recurrent Primary Sclerosing Cholangitis After Liver
Transplantation.
Am J Gastroenterol. 2025 Apr 7. doi: 10.14309/ajg.0000000000003423. PubMed
February 2025
XU L, Shen X, Xu Y Effects of Cholestasis on Primary Sclerosing Cholangitis in Patients Following
Liver Transplantation: Insights From Mixed Censoring Outcomes.
Am J Gastroenterol. 2025 Feb 5. doi: 10.14309/ajg.0000000000003313. PubMed
AZIZ B, Kok B, Cheah M, Lytvyak E, et al Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following
Liver Transplantation.
Am J Gastroenterol. 2025;120:459-468. PubMedAbstract available
December 2024
SINGAL AK, Pannerselvam D, Arab JP, Im G, et al Delisting From Liver Transplant List for Improvement and Re-compensation Among
Decompensated Patients at one-year.
Am J Gastroenterol. 2024 Dec 23. doi: 10.14309/ajg.0000000000003259. PubMedAbstract available
November 2024
KOHLI DR, Amateau S Judicious Use of Antibiotics in Liver Transplant Recipients Undergoing Endoscopic
Retrograde Cholangiopancreatography.
Am J Gastroenterol. 2024 Nov 25. doi: 10.14309/ajg.0000000000003185. PubMed
October 2024
BHUSHAN S, Sohal A, Kowdley KV, Agaf FF, et al Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Therapy Landscape.
Am J Gastroenterol. 2024 Oct 31. doi: 10.14309/ajg.0000000000003174. PubMedAbstract available
ZAVER HB, Rajpal N, Shah NL, Argo CK, et al MELD and MELD 3.0: What It Means for Your Practice.
Am J Gastroenterol. 2024;119:1951-1954. PubMed
August 2024
KOWDLEY KV, Hirschfield GM, Coombs C, Malecha ES, et al COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis
With Placebo and External Controls.
Am J Gastroenterol. 2024 Aug 14. doi: 10.14309/ajg.0000000000003029. PubMedAbstract available
July 2024
AZIZ B, Kok B, Cheah M, Lytvyak E, et al Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following
Liver Transplantation.
Am J Gastroenterol. 2024 Jul 25. doi: 10.14309/ajg.0000000000002977. PubMedAbstract available
DUKEWICH M, Dodge JL, Lucey MR, Rice JP, et al The Survival Benefit of Re-abstinence After Harmful Alcohol Use Following Early
Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multi-Center
ACCELERATE Study.
Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002956. PubMedAbstract available
LEE WM, Barnard C, Rule JA, Orandi BJ, et al Association of Acetaminophen (Paracetamol) Use with Severity and Outcomes in
Patients with Viral Hepatitis-Associated Acute Liver Failure.
Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002941. PubMedAbstract available
ARTZNER T, Goldberg DS, Sundaram V, Faitot F, et al Improvement in survival after transplantation for critically ill patients with
cirrhosis in the United States.
Am J Gastroenterol. 2024 Jul 5. doi: 10.14309/ajg.0000000000002944. PubMedAbstract available
June 2024
ELHENCE H, Dodge JL, Kahn JA, Lee BP, et al Characteristics and Outcomes Among U.S. Commercially Insured Transgender Adults
with Cirrhosis: A National Cohort Study.
Am J Gastroenterol. 2024 Jun 25. doi: 10.14309/ajg.0000000000002907. PubMedAbstract available
September 2023
NACHEF C, Bousson V, Belmatoug N, Cohen-Solal M, et al Osteoporosis and fragility fractures in patients with cirrhosis evaluated for
liver transplantation: Identification of high-risk patients based on computed
tomography at evaluation.
Am J Gastroenterol. 2023 Sep 20. doi: 10.14309/ajg.0000000000002507. PubMedAbstract available